发明授权
- 专利标题： Aminomethyl-4-imidazoles
- 专利标题（中）： 氨基甲基-4-咪唑
-
申请号： US11872203申请日： 2007-10-15
-
公开(公告)号： US08586617B2公开(公告)日： 2013-11-19
- 发明人: Guido Galley , Annick Goergler , Katrin Groebke Zbinden , Roger Norcross , Henri Stalder
- 申请人： Guido Galley , Annick Goergler , Katrin Groebke Zbinden , Roger Norcross , Henri Stalder
- 申请人地址： US NJ Nutley
- 专利权人： Hoffmann-La Roche Inc.
- 当前专利权人： Hoffmann-La Roche Inc.
- 当前专利权人地址： US NJ Nutley
- 优先权： EP06122586 20061019
- 主分类号： A61K31/417
- IPC分类号： A61K31/417 ; C07D233/64
摘要：
The present invention relates to amino-4-methyl imidazoles and pharmaceutically-acceptable salts thereof. The compound may be used for the treatment of depression, anxiety disorders, bipolar disorder, attention deficit hyperactivity disorder (ADHD), stress-related disorders, psychotic disorders such as schizophrenia, neurological diseases such as Parkinson's disease, neurodegenerative disorders such as Alzheimer's disease, epilepsy, migraine, hypertension, substance abuse and metabolic disorders such as eating disorders, diabetes, diabetic complications, obesity, dyslipidemia, disorders of energy consumption and assimilation, disorders and malfunction of body temperature homeostasis, disorders of sleep and circadian rhythm, and cardiovascular disorders.
公开/授权文献
- US20080119535A1 AMINOMETHYL-4-IMIDAZOLES 公开/授权日：2008-05-22
信息查询
IPC分类:
